Table 2.
Respondents’ opinion on CDTM agreements.
| n (%) | |
|---|---|
| CDTM | |
| Has a significant impact on patient health | 38 (69.1) |
| Can improve overall patient care | 47 (85.5) |
| Can reduce risk of drug related AEb or interactions | 46 (83.6) |
| Allow clinical pharmacists to be part of patient care | 46 (83.6) |
| Doesn't provide much help in patient care | 1 (1.8) |
| Actions can help to implement CDTM agreementsa | |
| Educate HCb providers about such agreement | 51 (96.2) |
| Convince SHb by providing evidence from the literature about CDTM role in HCb system | 39 (73.6) |
| Change clinical pharmacy practice in SAb so it can allow having such agreement | 42 (79.2) |
| Increase the number of clinical pharmacists who work in clinics | 43 (81.1) |
a
Total responses is not 100% (N = 53).
b
AE = adverse events; HC = health care; SH = stakeholders; SA = Saudi Arabia.